Search

Your search keyword '"Gago FE"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Gago FE" Remove constraint Author: "Gago FE"
22 results on '"Gago FE"'

Search Results

3. Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

4. TP73 DNA methylation and upregulation of ΔNp73 are associated with an adverse prognosis in breast cancer.

5. HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations.

6. Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.

7. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.

8. DNA methylation index and methylation profile of invasive ductal breast tumors.

9. Methylation profile of triple-negative breast carcinomas.

10. Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report.

11. Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA.

12. Stromal cell expression of caveolin-1 predicts outcome in breast cancer.

13. Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy.

14. P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.

15. Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.

16. Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy.

17. c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy.

18. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.

19. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy.

20. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.

21. Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

22. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients.

Catalog

Books, media, physical & digital resources